- Home
- BCYC vs NAPA Comparison
BCYC vs NAPA Comparison
Compare BCYC & NAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- NAPA
- Stock Information
- Founded
- BCYC 2009
- NAPA 1976
- Country
- BCYC United Kingdom
- NAPA United States
- Employees
- BCYC N/A
- NAPA N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- NAPA Beverages (Production/Distribution)
- Sector
- BCYC Health Care
- NAPA Consumer Staples
- Exchange
- BCYC Nasdaq
- NAPA Nasdaq
- Market Cap
- BCYC 1.7B
- NAPA 1.6B
- IPO Year
- BCYC 2019
- NAPA 2021
- Fundamental
- Price
- BCYC $15.59
- NAPA $11.09
- Analyst Decision
- BCYC Buy
- NAPA Hold
- Analyst Count
- BCYC 9
- NAPA 8
- Target Price
- BCYC $36.00
- NAPA $10.51
- AVG Volume (30 Days)
- BCYC 880.7K
- NAPA 1.5M
- Earning Date
- BCYC 10-31-2024
- NAPA 12-05-2024
- Dividend Yield
- BCYC N/A
- NAPA N/A
- EPS Growth
- BCYC N/A
- NAPA N/A
- EPS
- BCYC N/A
- NAPA 0.39
- Revenue
- BCYC $36,898,000.00
- NAPA $425,914,000.00
- Revenue This Year
- BCYC $40.52
- NAPA $22.74
- Revenue Next Year
- BCYC N/A
- NAPA $6.79
- P/E Ratio
- BCYC N/A
- NAPA $28.19
- Revenue Growth
- BCYC 48.60
- NAPA 7.19
- 52 Week Low
- BCYC $12.17
- NAPA $5.38
- 52 Week High
- BCYC $28.67
- NAPA $11.10
- Technical
- Relative Strength Index (RSI)
- BCYC 37.83
- NAPA 75.95
- Support Level
- BCYC $12.17
- NAPA $10.96
- Resistance Level
- BCYC $21.50
- NAPA $11.09
- Average True Range (ATR)
- BCYC 1.36
- NAPA 0.02
- MACD
- BCYC -0.36
- NAPA -0.04
- Stochastic Oscillator
- BCYC 49.67
- NAPA 83.33
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
About NAPA The Duckhorn Portfolio Inc.
The Duckhorn Portfolio Inc produces luxury and ultra-luxury wine across a portfolio of winery brands, including Duckhorn Vineyards, Paraduxx, Goldeneye, Migration, Decoy, Canvasback, Calera, Kosta Browne, Greenwing and Postmark. Its revenue is comprised of wholesale and direct-to-consumer sales. Wholesale revenue is generated through sales directly to California retailers and restaurants, sales to distributors and agents located in other states throughout the United States, and sales to export distributors that sell internationally.